Article may be outdated

This article is 4 days old. Some details may have changed since publication.

The Straits Times·3 min read·medium

Ketamine therapy at IMH for depression

J
Joyce Teo
Ketamine therapy at IMH for depression
AI Summary

Singapore's Institute of Mental Health is using intravenous ketamine to treat patients with treatment-resistant depression. The therapy has shown success in improving mood and reducing suicidal thoughts where traditional antidepressants have failed.

Ketamine, widely known as a party drug, has increasingly been harnessed as a treatment for depression.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in